Eagle Pharmaceuticals
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
50 Tice Blvd Ste 315, Woodcliff Lake, Ne...Phone Number
(201) 326-5300Website
www.eagleus.comRevenue
$257.6 MillionStock Symbol
EGRXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban for heparin-induced thrombocytopenia; Ryanodex for malignant hyperthermia; non-alcohol docetaxel injection, a chemotherapeutic agent for breast, non-small cell lung, prostate, head, and neck cancers/gastric adenocarcinoma; and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates includes include EP-4104, a dantrolene sodium for exertional heat stroke; EGL-4104-C-1702, dantrolene sodium for drug induced hyperthermia; EP-5101 (pemetrexed) for lung cancer and mesothelioma; and EGL-5385-C-1701 (fulvestrant) for breast cancer. Eagle Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Woodcliff Lake, New...Explore more
Eagle Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eagle Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Eagle Pharmaceuticals is spiking on competitors!
Check if Eagle Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Eagle Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Eagle Pharmaceuticals has new funding data
Product Launch: Get notified when Eagle Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Eagle Pharmaceuticals
Earning: See what the market has to say on Eagle Pharmaceuticals recently announced quarterly report
Eagle Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Eagle Pharmaceuticals
Compare insights from companies similar to Eagle Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Eagle Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eagle Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eagle Pharmaceuticals.
Eagle Pharmaceuticals financials insights
Gather financial insights about Eagle Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$50.3M
2022
Debt
$150M
Eagle Pharmaceuticals Tech Stack
A closer look at the technologies used by Eagle Pharmaceuticals
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Eagle Pharmaceuticals News & Media
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
Expanded collaboration significantly broadens ACA Pharma’s ex-U.S. commercialization footprint for RYANODEX® NEW YORK, NY, UNITED STATES, November 24, 2025 /EINPresswire.com/ -- ACA Pharma today announced a significant expansion of their exclusive …Indian Society of Anaesthesiologists Hosts Nationwide Launch of Ryanodex® in India
Perin Healthcare and ACA Pharma collaborate to strengthen malignant hyperthermia readiness across India through the introduction of Eagle Pharmaceutical's Ryanodex® MUMBAI, India and NEW YORK, Nov. 20, 2025 /PRNewswire-PRWeb/ -- The Indian Society of Anaesthesiologists (ISA), represented...Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
WOODCLIFF LAKE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has adopted an amendment (the “Amendment”) to its existing limited duration stockholder rights plan (as amended, the “Rights Plan”) to extend the duration of the Rights Plan by one year to October 30, 2026, effective immediately.Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
WOODCLIFF LAKE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the voting results for each of the matters presented at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”) held virtually on Friday, October 17, 2025. Of the 13,157,754 shares outstanding as of the record date, 10,769,820 shares, or approximately 82%, were present or represented by proxy at the Annual Meeting. Set
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eagle Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban for heparin-induced thrombocytopenia; Ryanodex for malignant hyperthermia; non-alcohol docetaxel injection, a chemotherap... Read More
